GLP-1 Drugs Are Lowering Americans’ Grocery Bills
Cornell University When Americans begin taking appetite-suppressing drugs like Ozempic and Wegovy, the changes extend well beyond the bathroom scale. According to new research, the…
Oprah Winfrey, 71, says she regrets not using GLP-1s sooner because of the ‘wasted sadness and shame’
Oprah Winfrey Theo Wargo/Getty Images Oprah Winfrey, 71, says she views GLP-1 medications as a “tool” to help her manage obesity. The “food noise” went away within hours on the first day she took a GLP-1 medication, she said. “I have regret that I didn’t discover it in 2013,” Winfrey said. Oprah Winfrey, 71, says […]
Weight-Loss Surgery or GLP-1s? Both Offer Sustained Fat Loss
Bariatric surgery and GLP-1 drugs are associated with reductions in fat mass and a shift in body composition toward a higher ratio of fat-free mass to fat mass over 2 years. Medscape Medical News
Butyrate — A Tiny Molecule with Big Potential for Health and Healing
Butyrate is a short-chain fatty acid (SCFA) produced in your gut when beneficial bacteria ferment dietary fiber, which your body cannot digest on its own. As the primary energy source for colonocytes (the cells lining your colon), butyrate provides up to 70% of their energy needs.1 However, its benefits go far beyond just fueling those […]
3 brilliant dividend shares to consider buying for 2026
At the start of a new year, when many people are reviewing their personal finances, income investors often look for promising dividend shares to add to their portfolios. And for good reason, as choosing the right stocks from day-one can turn an otherwise average year into one to celebrate. With that in mind, here are […]
Novo Nordisk CEO explains why new GLP-1 pill expands access to the weight loss drugs
Novo Nordisk CEO Mike Doustdar told Jim Cramer about developments in obesity treatment.
Dr. Drew Suggests GLP-1 Drugs Could Have Benefited Nick Reiner Amid Medicine Changes
Post Content
Novo Nordisk CEO: People have been waiting for a GLP-1 pill
Mike Doustdar, Novo Nordisk president and CEO, joins ‘Mad Money’ host Jim Cramer to talk the success of GLP-1, pricing for weight-loss pills and more.
Novo Nordisk CEO: Wegovy not only reduces your weight, but it also shows cardiovascular benefits
Mike Doustdar, Novo Nordisk president and CEO, joins ‘Mad Money’ host Jim Cramer to talk the success of GLP-1, pricing for weight-loss pills and more.
Stopping GLP-1 Weight Loss Drugs Leads to Fast Rebound in Weight and Heart Risks, Study Warns
Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to sustain once treatment ends. Stopping treatment with weight loss medications is associated with gradual weight gain and a loss of earlier improvements in heart and metabolic health, according to new research published by The BMJ. The study […]